Skip to main content
Pandemics, Patents, and Price Controls
Researchers at the UW Medicine Retrovirology Research Lab at Harborview Medical Center work on samples from the Novavax phase 3 Covid-19 clinical vaccine trial on February 12, 2021 in Seattle, Washington
(Photo by Karen Ducey/Getty Images)

Pandemics, Patents, and Price Controls

Adam Mossoff

Summary

The COVID-19 pandemic has shown the world what decades of patent protection has made possible in the biopharmaceutical sector of the U.S. innovation economy. Nonetheless, price controls now threaten to stifle this innovation. If the government twists its own laws and arbitrarily imposes price controls on patented vaccines and drugs created by pharmaceutical innovators, innovation will not occur. Statist price controls kill innovation, destroy markets, and stymie or degrade economic development. We should prevent politicians and activists from exploiting the COVID-19 crisis to undermine both patents and biopharmaceutical advancement—harming people today and preventing an effective response to the next pandemic.

Read the full report in Heritage Foundation

Related Articles

Transcript: Investigating COVID-19 and the China Coverup

David Asher et al.

Following is the full transcript of the Hudson Institute event titled Investigating COVID-19 and the China Coverup ...

Continue Reading

The COVID-19 Intellectual Property Waiver: Threats to US Innovation, Economic Growth, and National Security

Adam Mossoff

The COVID-19 pandemic, as well as growing economic and strategic competition from China and traditional competitors, have made U.S. innovation, econom...

Continue Reading

Transcript: An Allied Response to Beijing’s COVID Obstructionism

David Asher & John P. Walters

Following is the full transcript of the Hudson Institute event titled An Allied Response to Beijing’s COVID Obstructionism ...

Continue Reading